Morgan Stanley upgrades RH to Overweight with $530 price target, citing positive inflection and long-term fundamentals. Latest Ratings for RH Date Firm Action From To Mar 2022 Wells Fargo Maintains Overweight Jan 2022 Citigroup Maintains Buy Sep 2021 UBS Maintains Neutral View More Analyst Ratings for RH View the Latest Analyst Ratings read more
Lantheus shares are trading lower by 5.4% during Monday’s session. The company announced a $350 million acquisition. read more
Apple’s iPhones lost ground in China as domestic players gained traction in 2024. Counterpoint predicts market recovery in 2024 after decline. read more
Amid LA wildfires, analyst picks Douglas Emmett Inc as a long-term beneficiary of rebuilding efforts. Office space demand expected to increase. Latest Ratings for DEI Date Firm Action From To Mar 2022 Evercore ISI Group Upgrades In-Line Outperform Jan 2022 Raymond James Upgrades Market Perform Outperform Dec 2021 Wells Fargo Upgrades Equal-Weight Overweight View More…
Shares of BioNTech fell 4% on Monday. Vaccine stocks are volatile after Moderna’s updated revenue guidance for 2025, which fell below analyst expectations. read more
IonQ Inc (NYSE:IONQ) shares are trading lower Monday alongside several other quantum computing stocks as the quantum sector continues to face selling pressure on the back of cautious commentary from Nvidia Corp (NASDAQ:NVDA) CEO Jensen Huang. read more
